Cargando…

Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)

Intravenous immunoglobulin (IVIG), a pooled normal IgG from several thousand healthy donors and one of the commonly used immunotherapeutic molecules for the management of autoimmune and inflammatory diseases, has been explored for the treatment of coronavirus disease‐19 (COVID‐19). Although placebo‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	News & Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565103/ https://www.ncbi.nlm.nih.gov/pubmed/33088506 http://dx.doi.org/10.1002/cti2.1198

Ejemplares similares

Autoimmune and inflammatory diseases following COVID-19
por: Galeotti, Caroline, et al.
Publicado: (2020)

Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
por: Bayry, Jagadeesh, et al.
Publicado: (2004)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2016)

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2020)

Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
por: Galeotti, Caroline, et al.
Publicado: (2016)

Intravenous Immunoglobulin Therapy Eliminates Candida albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis
por: Charlet, Rogatien, et al.
Publicado: (2019)

Acid Stripping of Surface IgE Antibodies Bound to FcεRI Is Unsuitable for the Functional Assays That Require Long-Term Culture of Basophils and Entire Removal of Surface IgE
por: Galeotti, Caroline, et al.
Publicado: (2020)

High risk of autoimmune diseases after COVID-19
por: Sharma, Chetan, et al.
Publicado: (2023)

Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cells
por: Karnam, Anupama, et al.
Publicado: (2020)

Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients
por: Sharma, Meenu, et al.
Publicado: (2014)

Cross-presentation of antigens by dendritic cells: role of autophagy
por: Das, Mrinmoy, et al.
Publicado: (2015)

Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy
por: Das, Mrinmoy, et al.
Publicado: (2020)

Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2
por: Hegde, Pushpa, et al.
Publicado: (2011)

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy
por: Maddur, Mohan S., et al.
Publicado: (2017)

Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
por: Jawhara, Samir
Publicado: (2020)

Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN
por: Saha, Chaitrali, et al.
Publicado: (2017)

Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity
por: Gupta, Nimesh, et al.
Publicado: (2013)

Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?
por: López-Medrano, Francisco, et al.
Publicado: (2021)

Human circulating basophils lack the features of professional antigen presenting cells
por: Sharma, Meenu, et al.
Publicado: (2012)

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4(+) T Cell Responses
por: Saha, Chaitrali, et al.
Publicado: (2016)

Correction: Saha, C., et al. Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4(+) T Cell Responses. Molecules 2016, 21, 912
por: Saha, Chaitrali, et al.
Publicado: (2019)

Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme
por: Wiatr, Marie, et al.
Publicado: (2019)

Intravenous Immunoglobulin for Treatment of Severe Coronavirus Disease 19 (COVID-19) – A Literature Overview
por: Rizvi, Syed, et al.
Publicado: (2021)

The Homophilic Domain – An Immunological Archetype
por: Kohler, Heinz, et al.
Publicado: (2016)

Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids
por: Ayesh, Hazem, et al.
Publicado: (2021)

Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin
por: Lion, Julien, et al.
Publicado: (2017)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2016)

The original sins of clinical trials with intravenous immunoglobulins in sepsis
por: Almansa, Raquel, et al.
Publicado: (2015)

Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017)

Autoimmunity as a Predisposition for Infectious Diseases
por: Maddur, Mohan S., et al.
Publicado: (2010)

Incidence, Pathophysiology, and Impact of Coronavirus Disease 2019 (COVID-19) on Acute Ischemic Stroke
por: Majmundar, Neil, et al.
Publicado: (2020)

Unraveling the mechanisms of IVIG immunotherapy in MIS-C
por: Ganigara, Madhusudan, et al.
Publicado: (2021)

Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer
por: Elluru, Sri Ramulu, et al.
Publicado: (2008)

Circulating human basophils lack the features of professional antigen presenting cells
por: Sharma, Meenu, et al.
Publicado: (2013)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011)

COVID-19: A Veterinary and One Health Perspective
por: Kumar, Deepak, et al.
Publicado: (2022)

Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
por: Saha, Chaitrali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qm2116j39u80mm51feh8oo5cgj